Stuttgart - Delayed Quote EUR
Glass House Brands Inc (4KF0.SG)
5.35
-0.45
(-7.76%)
At close: May 16 at 9:33:55 PM GMT+2
Loading Chart for 4KF0.SG
- Previous Close
5.80 - Open
5.65 - Bid 5.30 x --
- Ask 5.85 x --
- Day's Range
5.35 - 5.70 - 52 Week Range
1.87 - 8.90 - Volume
0 - Avg. Volume
14 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 4KF0.SG
View MorePerformance Overview: 4KF0.SG
Trailing total returns as of 5/18/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
4KF0.SG
7.00%
MSCI WORLD (^990100-USD-STRD)
4.19%
1-Year Return
4KF0.SG
36.69%
MSCI WORLD (^990100-USD-STRD)
11.25%
3-Year Return
4KF0.SG
31.85%
MSCI WORLD (^990100-USD-STRD)
44.96%
5-Year Return
4KF0.SG
31.85%
MSCI WORLD (^990100-USD-STRD)
86.72%
Compare To: 4KF0.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
5.35
-7.76%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6000
-4.76%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0070
0.00%
Mkt Cap EUR 2.503M
Industry Drug Manufacturers—Specialty & Generic
1.1840
+8.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.4950
+3.45%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.0960
+5.19%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.2720
+1.44%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.4100
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0700
0.00%
Mkt Cap EUR 12.693M
Industry Drug Manufacturers—Specialty & Generic
0.5850
-4.88%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.5750
+5.29%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 4KF0.SG
View MoreValuation Measures
As of 5/16/2025
Market Cap
424.70M
Enterprise Value
461.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.14
Price/Book (mrq)
3.60
Enterprise Value/Revenue
2.40
Enterprise Value/EBITDA
11.24
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--